Stocks · Health care · Pharmaceutical Preparations

Spero Therapeutics, Inc.

SPRO Clue Score50
United States Fiscal year ends December CIK 0001701108 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Ankit Mahadevia
27 Dec 2021
CEO and President
Sold after exercise
8,000
$14.58
$116.67K
Cristina Larkin
16 Dec 2020
Chief Operating Officer
Sold after exercise
12,000
$19.00
$228.00K
Ankit Mahadevia
4 Nov 2020
CEO and President
Sold after exercise
7,370
$14.43
$106.34K
Ankit Mahadevia
3 Nov 2020
CEO and President
Sold after exercise
2,137
$14.27
$30.49K
Ankit Mahadevia
23 Oct 2020
CEO and President
Sold after exercise
20
$14.25
$285.00
Ankit Mahadevia
14 Oct 2020
CEO and President
Sold after exercise
105
$14.25
$1.50K
Ankit Mahadevia
13 Oct 2020
CEO and President
Sold after exercise
14,367
$14.28
$205.21K
Ankit Mahadevia
8 Sep 2020
CEO and President
Sold after exercise
774
$14.25
$11.03K
Ankit Mahadevia
9 Jul 2020
CEO and President
Sold after exercise
2,293
$14.31
$32.81K
Ankit Mahadevia
7 Jul 2020
CEO and President
Sold after exercise
754
$14.25
$10.74K
Ankit Mahadevia
25 Jun 2020
CEO and President
Sold after exercise
2,642
$14.25
$37.65K
Ankit Mahadevia
24 Jun 2020
CEO and President
Sold after exercise
3,880
$14.28
$55.42K
Ankit Mahadevia
23 Jun 2020
CEO and President
Sold after exercise
8,045
$14.33
$115.26K
Ankit Mahadevia
22 Jun 2020
CEO and President
Sold after exercise
2,613
$14.30
$37.36K
Ankit Mahadevia
6 Jul 2018
See Remarks
Sold after exercise
200
$17.92
$3.58K
Ankit Mahadevia
6 Jul 2018
See Remarks
Sold after exercise
200
$17.90
$3.58K
Ankit Mahadevia
6 Jul 2018
See Remarks
Sold after exercise
100
$17.71
$1.77K
Ankit Mahadevia
6 Jul 2018
See Remarks
Sold after exercise
100
$17.62
$1.76K
Ankit Mahadevia
6 Jul 2018
See Remarks
Sold after exercise
400
$17.58
$7.03K
Ankit Mahadevia
6 Jul 2018
See Remarks
Sold after exercise
100
$17.55
$1.75K
Ankit Mahadevia
6 Jul 2018
See Remarks
Sold after exercise
500
$17.50
$8.75K
Ankit Mahadevia
5 Jul 2018
See Remarks
Sold after exercise
3,076
$17.62
$54.20K
Joel Sendek
5 Jul 2018
Chief Financial Officer
Sold after exercise
2,000
$17.50
$35.00K
Cristina Larkin
5 Jul 2018
Chief Operating Officer
Sold after exercise
4,000
$17.50
$70.00K

What was left out

Form 4 filings counted 197
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 23
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 24
Sales at will 53
Transactions with no price 0
Shares from compensation/vesting 13,007,082
Sales filed before the plan box existed 18
History held since 7 Nov 2017